title: Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients.
authors.affiliation: Institut IMAGINE, Unité INSERM U1163, Paris, France Département de Pathologie, Groupe Henri-Mondor Albert-Chenevier, Assistance Publique - Hôpitaux de Paris, Créteil, France Unité INSERM U955, Créteil, France.
authors.forename: Mathilde
authors.initials: M
authors.lastname: Lamarque
authors.affiliation: Service d'Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire, Hôtel Dieu, Nantes, France.
authors.forename: Céline
authors.initials: C
authors.lastname: Bossard
authors.affiliation: Unité Hémopathies Lymphoïdes, Groupe Henri Mondor Albert-Chenevier, Assistance Publique - Hôpitaux de Paris, Créteil, France Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
authors.forename: Adrien
authors.initials: A
authors.lastname: Contejean
authors.affiliation: Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
authors.affiliation: Département de Pathologie, Hôpital Pessac, Bordeaux, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Parrens
authors.affiliation: Service d'Hématologie Clinique, Unité d'Investigation Clinique, Centre Hospitalier Universitaire de Nantes, France Unité INSERM, UMR892 - CNRS, UMR 6299, Université de Nantes, France.
authors.forename: Steven
authors.initials: S
authors.lastname: Le Gouill
authors.affiliation: Département de Pathologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
authors.forename: Josette
authors.initials: J
authors.lastname: Brière
authors.affiliation: Service d'onco-hématologie adulte, Institut Paoli-Calmettes, Marseille, France.
authors.forename: Reda
authors.initials: R
authors.lastname: Bouabdallah
authors.affiliation: Département de Pathologie, Hôpital Necker, Assistance Publique, Hôpitaux de Paris, France.
authors.forename: Danielle
authors.initials: D
authors.lastname: Canioni
authors.affiliation: Département d'hématologie clinique, Centre Henri Becquerel, Rouen, France Unité INSERM U918, Centre Henri Becquerel, Rouen, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Tilly
authors.affiliation: Département de pathologie, CHU de Lille, France.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Bouchindhomme
authors.affiliation: Département d'hématologie clinique, Hospices Civils de Lyon, Université Claude Bernard Lyon-1, Pierre Bénite, France Unité CNRS UMR5239, Lyon, France Faculté de médecine Lyon Sud Charles Mérieux, Hôpitaux de Paris, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Bachy
authors.affiliation: Service d'Hématologie, Hôpital Necker, Assistance Publique, Hôpitaux de Paris, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Delarue
authors.affiliation: Unité INSERM U955, Créteil, France Unité Hémopathies Lymphoïdes, Groupe Henri Mondor Albert-Chenevier, Assistance Publique - Hôpitaux de Paris, Créteil, France Université Paris Est, Créteil, France.
authors.forename: Corinne
authors.initials: C
authors.lastname: Haioun
authors.affiliation: Département de Pathologie, Groupe Henri-Mondor Albert-Chenevier, Assistance Publique - Hôpitaux de Paris, Créteil, France Unité INSERM U955, Créteil, France Université Paris Est, Créteil, France philipe.gaulard@aphp.fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Gaulard
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D005260:Female; D005602:France; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D017730:Ki-1 Antigen / Q000235:genetics* / Q000378:metabolism; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D015398:Signal Transduction; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents; D018796:Immunoconjugates; D017730:Ki-1 Antigen; D000079963:Brentuximab Vedotin
keywords: brentuximab vedotin; primary cutaneous T-cell lymphoma; refractory; relapsed; systemic anaplastic large-cell lymphoma